A wasting disease is any condition that causes severe, progressive loss of body weight, muscle mass, and fat that the body cannot recover through normal eating. The term covers a range of conditions in both humans and animals, from cancer-related wasting (cachexia) to the prion disease that affects deer and elk. What ties them together is the hallmark pattern: the body breaks itself down faster than it can rebuild, and simply eating more doesn’t fix it.
Wasting Disease in Humans: Cachexia
The most common form of wasting disease in people is cachexia, a severe syndrome tied to chronic illnesses like cancer, HIV, heart failure, and kidney disease. It’s formally diagnosed when someone loses more than 5% of their body weight over six months, or more than 2% if they already have a low body mass index or reduced muscle mass. Cachexia accounts for roughly 20% of all cancer-related deaths, making it far more than a side effect. It’s a life-threatening condition on its own.
Not every cancer carries the same risk. Up to 87% of people with pancreatic or gastric cancer develop cachexia, while around 61% of those with colon, lung, or prostate cancer experience it. Even cancers with lower overall rates, like breast cancer and leukemia, still cause cachexia in about 40% of patients. Cancers of the gastrointestinal tract and lungs are especially prone to triggering the syndrome because tumors in these areas release compounds that push the body into a relentless breakdown state.
Why Eating More Doesn’t Help
This is the part that surprises most people. Cachexia is not starvation. During actual starvation, the body adapts intelligently: it slows its metabolism, preferentially burns fat stores, and works hard to preserve muscle and organ function. Appetite increases, and if food becomes available again, the body recovers.
Cachexia does the opposite. The body burns through both muscle and fat at an accelerated rate, even when calorie intake is adequate. Resting energy expenditure actually increases because the normal energy-production machinery inside cells becomes inefficient, generating heat instead of usable energy. The body acts as if it’s under siege, breaking down its own tissues to fuel an inflammatory response it can’t shut off. This is why standard nutritional support, whether high-calorie diets, supplements, or feeding tubes, cannot fully reverse the weight loss.
The Inflammation Driving the Breakdown
Chronic, body-wide inflammation is the engine behind cachexia. Tumors and immune cells release signaling molecules that hijack the body’s normal metabolic processes. These inflammatory signals directly attack muscle tissue, activating protein-degradation pathways that chew through muscle fibers faster than the body can rebuild them. At the same time, they suppress the signals that would normally trigger muscle repair and growth.
The result is a body locked in a catabolic state, meaning it’s constantly tearing down more tissue than it’s building. Muscles release their amino acids into the bloodstream, where they’re diverted to fuel the immune response or consumed by the tumor itself. Some tumors are particularly greedy for specific amino acids like glutamine, which further accelerates muscle breakdown. Even the heart muscle can be affected, contributing to the fatigue and weakness that define the experience of living with cachexia.
What Cachexia Feels Like
The earliest stage, called pre-cachexia, starts with subtle weight loss (under 5% of body weight), reduced appetite, and metabolic changes that may not yet be visible. As the condition progresses, the symptoms become impossible to ignore: deep fatigue, loss of appetite or feeling full after just a few bites, nausea, bloating, and progressive physical weakness. People often describe feeling too tired to complete everyday tasks.
Physical function declines in lockstep with weight loss. Research on pancreatic cancer patients found a strong correlation between weight gain and improved physical function, and the reverse is equally true. Exercise programs, while theoretically helpful, are often limited by the reality that many patients with advanced cachexia simply aren’t functional enough to perform them. The combination of muscle loss, fatigue, and reduced appetite creates a cycle that becomes harder to interrupt as the disease advances.
Treatment Options Remain Limited
There is currently no widely approved treatment that reliably reverses cachexia. One of the more studied approaches targets ghrelin, the hormone your stomach produces to signal hunger and stimulate growth. An oral medication that mimics ghrelin’s effects was approved in Japan in 2020 for cancer-related wasting after trials showed it could increase body weight. However, regulators in the United States and Europe declined to approve it, noting that the weight gain didn’t translate into meaningful improvements in muscle strength or quality of life.
Current management focuses on a combination of nutritional support, appetite-stimulating medications, and, when possible, treating the underlying disease. None of these approaches alone is sufficient, and evidence remains too thin to strongly endorse any single drug for the condition. For many patients, controlling cachexia means slowing the decline rather than reversing it.
HIV-Associated Wasting
Before effective antiviral therapy became available, wasting was so common in HIV that it earned its own name: “slim disease.” HIV-associated wasting syndrome is still a recognized diagnosis, defined by involuntary weight loss of more than 10% of baseline body weight along with chronic diarrhea, weakness, or fever. The same inflammatory and catabolic mechanisms behind cancer cachexia are at work here, driven by the immune system’s prolonged battle against the virus. Modern antiretroviral treatment has dramatically reduced the incidence of HIV wasting, but it still occurs in people with uncontrolled infections or limited access to treatment.
Age-Related Muscle Wasting: Sarcopenia
Sarcopenia is a different kind of wasting that comes with aging. First defined in 1989 as a “muscle-wasting geriatric syndrome,” it involves the gradual loss of skeletal muscle mass and strength that accelerates as people get older. Unlike cachexia, sarcopenia isn’t driven by a specific disease or runaway inflammation. It’s a slower, more predictable process tied to declining hormone levels, reduced physical activity, and changes in how the body processes protein. The distinction matters because sarcopenia responds much better to intervention, particularly resistance exercise and adequate protein intake, in ways that cachexia does not.
Chronic Wasting Disease in Animals
When people search for “wasting disease,” they’re often thinking of chronic wasting disease (CWD), the fatal condition affecting deer, elk, moose, and reindeer. CWD is caused by prions, proteins that exist normally in the body but occasionally misfold into a shape that causes a chain reaction, forcing other proteins to misfold as well. This process gradually destroys brain tissue and is always fatal. Infected animals develop drastic weight loss, stumbling, drooling, and listlessness before dying.
CWD spreads between animals through saliva, feces, blood, and urine, either by direct contact or through contaminated soil and water. Once prions are established in an environment, they persist in the soil for years, making the disease extremely difficult to eradicate from a region. This environmental persistence is one reason wildlife agencies track CWD so closely.
Can CWD Spread to Humans?
This is the question hunters and people living in affected areas most want answered. So far, the evidence points to a strong species barrier. In a 2024 study published by the CDC, researchers exposed lab-grown human brain tissue to high concentrations of CWD prions from three different sources and monitored them for up to 180 days. No human prion propagation occurred. Separately, studies in macaque monkeys (a closer biological model to humans than other primates) found no signs of prion infection even 13 years after direct inoculation with CWD. This stands in sharp contrast to mad cow disease (BSE), which readily transmitted to the same type of monkey and has caused confirmed human illness.
That said, the CDC still considers CWD’s risk to humans “unknown” rather than zero. The agency recommends that hunters in areas where CWD has been detected have their animals tested before eating the meat and avoid consuming meat from animals that test positive.